%D9%81%D9%88%D8%B1%D9%88%D8%B3%D9%8A%D9%85%D9%8A%D8%AF%D9%81%D9%88%D8%B1%D9%88%D8%B2%D9%85%D8%A7%DB%8C%D8%AFFurosemidaCategory:FurosemideFfwrosemidFurosemidFurosemideFurosemidaFurosemiid%D9%81%D9%88%D8%B1%D9%88%D8%B2%D9%85%D8%A7%DB%8C%D8%AFFurosemidiFuros%C3%A9mide%D7%A4%D7%95%D7%A8%D7%95%D7%A1%D7%9E%D7%99%D7%93FurosemidFuroszemid%D5%96%D5%B8%D6%82%D6%80%D5%B8%D5%BD%D5%A5%D5%B4%D5%AB%D5%A4FurosemidaFurosemide%E3%83%95%E3%83%AD%E3%82%BB%E3%83%9F%E3%83%89%ED%91%B8%EB%A1%9C%EC%84%B8%EB%AF%B8%EB%93%9CFurosemidumFurosem%C4%ABds%D0%A4%D1%83%D1%80%D0%BE%D1%81%D0%B5%D0%BC%D0%B8%D0%B4FurosemidaFurosemideFurosemid%E0%AC%AB%E0%AD%81%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AD%87%E0%AC%AE%E0%AC%BE%E0%AC%87%E0%AC%A1FurosemidFurosemidaFurosemid%C4%83%D0%A4%D1%83%D1%80%D0%BE%D1%81%D0%B5%D0%BC%D0%B8%D0%B4FurosemidFurosemidFurosemidFurosemid%E0%B8%9F%E0%B8%B9%E0%B9%82%E0%B8%A3%E0%B8%8B%E0%B8%B5%E0%B9%84%E0%B8%A1%E0%B8%94%E0%B9%8C%D0%A4%D1%83%D1%80%D0%BE%D1%81%D0%B5%D0%BC%D1%96%D0%B4FurosemideQ388801%E5%91%8B%E5%A1%9E%E7%B1%B3
about
P3781
Health hazard evaluation report: evaluation of safety climate, health concerns, and pharmaceutical dust exposures at a mail order pharmacyDiuretics and mortality in acute renal failure.Recent developments in analytical determination of furosemide.Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutationGlucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapyA rare cause of postpartum acute hyponatremiaMicellisation Mechanism and Behaviour of Soluplus®⁻Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based SystemOutdoor temperature and survival benefit of empiric potassium in users of furosemide in US Medicaid enrollees: a cohort study
P921
Q147778-36BD4FD6-92A4-4CB2-AB48-8C790C3C1397Q19000661-43E94EEB-B9A5-433A-9BD0-22014F6761ECQ190805-BF59408D-62DA-4739-9FDF-8DA8F92F273AQ41861-7D74C7AF-AC96-42A1-B13F-9B2E6F237C5DQ486485-DE2883F8-4E79-4770-BF47-2B951BEA63A1Q504790-CB3EFC26-13B0-4F69-A700-519F6F6EACAAQ612681-9B0B6CA8-B621-4F00-81FC-CDB69FB1B795Q736715-A358A689-0735-4878-949C-FB25943E5C86Q857667-8697E524-E7D5-4E3F-B051-56FF0EFA6142Q929737-965AA039-7774-4600-86EF-1C11827A0CA3
P2176
Q24706840-72CB7C41-0C08-41DD-A7D9-458D164DFD18Q34337690-F15A3F36-27DA-465E-954F-F6809CB05E89Q37243014-275367ED-E85E-4286-AED2-E3F94D85DF1BQ61796880-D0648BE8-B84B-4EA9-960F-B0B17D51AD1EQ64062019-D919E49A-7506-4900-B103-A0D5CF2BDF33Q64086466-B17D8CF3-0445-4CDD-BD2F-C1328405DDD0Q64230494-AAD9A6DB-DDF1-40F5-874D-6C9F77244F90Q64236342-97B9D535-1B35-4615-9992-F73B2168962A
P921
description
Arzneistoff
@de
Medikamentu diuretikoa, gorputzetik ura eta elektrolitoak azkar kanporarazten dituena
@eu
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Furosemid
@de
Furosemid
@hr
Furosemid
@pl
Furosemid
@sh
Furosemid
@sl
Furosemid
@sr
Furosemid
@sv
Furosemida
@ms
Furosemide
@id
Furosemide
@nl
type
label
Furosemid
@de
Furosemid
@hr
Furosemid
@pl
Furosemid
@sh
Furosemid
@sl
Furosemid
@sr
Furosemid
@sv
Furosemida
@ms
Furosemide
@id
Furosemide
@nl
altLabel
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
@en
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
@en
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
@en
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
@en
Frusemide
@en
Furosemid
@en
Furosemida
@en
Furosemide
@en
Furosemidu
@en
Furosemidum
@en
prefLabel
Furosemid
@de
Furosemid
@hr
Furosemid
@pl
Furosemid
@sh
Furosemid
@sl
Furosemid
@sr
Furosemid
@sv
Furosemida
@ms
Furosemide
@id
Furosemide
@nl